You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I adult Hodgkin lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Papillomavirus Infections, Oropharyngeal Tumors Trial run by the NCI (E7 T-Cell Receptor (TCR))

Terminated
Has Results
  • Papillomavirus Infections
  • Oropharyngeal Neoplasms
  • E7 T-Cell Receptor (TCR)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 3, 2022

Breast Cancer Female, Acute Leukemia, Lymphoma Trial in Sweden (Triptorelin Embonate, Sodium Chloride solution 0.9%)

Not yet recruiting
  • Breast Cancer Female
  • +5 more
  • Triptorelin Embonate
  • Sodium Chloride solution 0.9%
  • Göteborg, Sweden
  • +16 more
Oct 26, 2022

Multiple Myeloma Trial in Bethesda, Oklahoma City, Fairfax (Descartes-08, Fludarabine, Cyclophosphamide)

Completed
  • Multiple Myeloma
  • Descartes-08
  • +2 more
  • Bethesda, Maryland
  • +2 more
Mar 10, 2022

Patients With Cholangiocarcinoma and Gallbladder Cancer

Recruiting
  • Biliary Tract Cancer
  • +2 more
    • Herlev, Copenhagen, Denmark
      Herlev & Gentofte Hospital
    Dec 21, 2021

    Multiple Myeloma Trial in San Francisco (Free light chains)

    Recruiting
    • Multiple Myeloma
    • Free light chains
    • San Francisco, California
      San Francisco General Hospital
    Mar 23, 2022

    MDD Trial in United States (BTRX-335140, Placebo)

    Active, not recruiting
    • Major Depressive Disorder
    • Phoenix, Arizona
    • +37 more
    Mar 11, 2022

    metAsTatI? melanOma Treated With dabrafeNib and trAmetinib in

    Recruiting
    • Melanoma Stage III
    • +2 more
    • Barnaul, Alatai, Russian Federation
    • +14 more
    May 29, 2022

    Drug-drug Interactions Trial in DeLand (napabucasin, cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate)

    Completed
    • Drug-drug Interactions
    • napabucasin
    • cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate
    • DeLand, Florida
      Accel Research Sites
    Apr 4, 2022

    Carcinoma, Hepatocellular Trial (Regorafenib in combination with nivolumab, Transarterial Chemoembolization (TACE))

    Not yet recruiting
    • Carcinoma, Hepatocellular
    • Regorafenib in combination with nivolumab
    • Transarterial Chemoembolization (TACE)
    • (no location specified)
    Dec 8, 2021

    Acute Chorea Trial in Luxor (Laparoscopic cholecystectomy)

    Completed
    • Acute Chorea
    • Laparoscopic cholecystectomy
    • Luxor, Egypt
      Mohammed Ahmed Omar
    Feb 9, 2023

    Differences Between Women With COVID-19 and Long Covid

    Recruiting
    • COVID-19
    • Questionnaires
    • Valencia, Spain
      University of Valencia
    Jan 2, 2023

    T Cell Lymphoma Trial in Seoul (ACHOP)

    Not yet recruiting
    • T Cell Lymphoma
    • Seoul, Korea, Republic of
      81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
    Apr 18, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • Metastatic Malignant Solid Neoplasm
    • Biopsy
    • +3 more
    • (no location specified)
    Jan 18, 2023

    Dental Caries Trial in Dallas (silver diamine fluoride, 38%, Sodium fluoride gel, 5000 PPM)

    Not yet recruiting
    • Dental Caries
    • silver diamine fluoride, 38%
    • Sodium fluoride gel, 5000 PPM
    • Dallas, Texas
      Baylor College of Dentistry
    May 30, 2022

    Diabetes Trial in Heidelberg, Aschaffenburg (FiberSense CGM)

    Recruiting
    • Diabetes
    • FiberSense CGM
    • Heidelberg, Baden-Württemberg, Germany
    • +2 more
    Oct 18, 2022

    Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage III Soft Tissue Sarcoma of the Trunk and Extremities

    Recruiting
    • Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
    • +3 more
    • Chest Radiography
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 28, 2022

    Colorectal Cancer Trial in Wenzhou (mFOLFOXIRI, mFOLFOX6 OR CapeOx)

    Recruiting
    • Colorectal Cancer
    • Wenzhou, Zhejiang, China
      The First Affiliated Hospital of Wenzhou Medical University
    Jan 18, 2022

    Chemo-Induced Nausea and Vomiting (CINV) Trial in Canton (SUSTOL)

    Recruiting
    • Chemotherapy-Induced Nausea and Vomiting (CINV)
    • Canton, Ohio
      Gabrail Cancer Center Research
    Jul 15, 2022

    Mood Change, Depressive Symptoms, Anxiety Generalized Trial in White Plains (Integrative-Mind-Body Skills Group)

    Not yet recruiting
    • Mood Change
    • +2 more
    • Integrative-Mind-Body Skills Group
    • White Plains, New York
      Weill Cornell Medical College
    Nov 9, 2022

    Periodontitis, Gingivitis, Dental Caries Trial in Reims (Numerical dental impression by intraoral scanner)

    Recruiting
    • Periodontitis
    • +3 more
    • Numerical dental impression by intraoral scanner
    • Reims, France
      Damien JOLLY
    Aug 17, 2023

    Aging Disorder Trial in Vandoeuvre les Nancy (PET with a cerebral step, Central blood pressure measurement, Neurocognitive

    Active, not recruiting
    • Aging Disorder
    • PET with a cerebral step
    • +2 more
    • Vandoeuvre les Nancy, France
      CHRU Nancy
    Sep 30, 2021

    Spinal Muscular Atrophy Trial (NMD670, Placebo)

    Not yet recruiting
    • Spinal Muscular Atrophy
    • (no location specified)
    Mar 29, 2023

    Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

    Active, not recruiting
    • Mycoses
    • +5 more
    • anti-thymocyte globulin
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    Jun 16, 2022

    Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)

    Not yet recruiting
    • Colon Cancer
    • mFOLFIRINOX-FOLFIRI intensified chemotherapy
    • FOLFOX or CAPOX adjuvant chemotherapy
    • (no location specified)
    Sep 6, 2022

    Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

    Completed
    • Colorectal Cancer Metastatic
    • C-met Overexpression
    • Tivantinib (ARQ197)
    • Rozzano, Milano, Italy
      Istituto Clinico Humanitas
    Sep 8, 2022